We are live on ! Find out more
FCMT

Founders Capital Management (Texas) Portfolio holdings

AUM $231M
1-Year Est. Return 61.68%
This Fund
S&P 500
This Quarter Est. Return
+8.83%
1 Year Est. Return
+61.68%
3 Year Est. Return
+118.08%
5 Year Est. Return
+149.3%
10 Year Est. Return
AUM
$138M
AUM Growth
+$6.68M
Cap. Flow
-$2.89M
Cap. Flow %
-2.1%
Top 10 Hldgs %
50.15%
Holding
410
New
8
Increased
43
Reduced
63
Closed
29

Sector Composition

Rank Sector Weight
1 Technology 19.7%
2 Industrials 16.15%
3 Energy 11.66%
4 Healthcare 10.85%
5 Consumer Discretionary 6.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TREE icon
351
LendingTree
TREE
$453M
$2.3K ﹤0.01%
76
IYT icon
352
iShares US Transportation ETF
IYT
$2.27B
$2.1K ﹤0.01%
32
FTEC icon
353
Fidelity MSCI Information Technology Index ETF
FTEC
$21.1B
$1.75K ﹤0.01%
12
KPTI icon
354
Karyopharm Therapeutics
KPTI
$44.4M
$1.73K ﹤0.01%
133
SLYV icon
355
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.04B
$1.72K ﹤0.01%
21
+1
+5% +$74
TSE
356
DELISTED
Trinseo
TSE
$1.67K ﹤0.01%
200
-100
-33% -$669
FLNA
357
Filana Therapeutics
FLNA
$48.2M
$1.58K ﹤0.01%
70
VNRX icon
358
VolitionRx Ltd
VNRX
$9.24M
$1.43K ﹤0.01%
100
-100
-50% -$1.47K
BEP icon
359
Brookfield Renewable
BEP
$9.8B
$1.24K ﹤0.01%
47
+14
+42% +$332
CTRA
360
DELISTED
Coterra Energy
CTRA
$1.2K ﹤0.01%
47
SGMO
361
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.09K ﹤0.01%
2,000
-2,000
-50% -$922
CAPL icon
362
CrossAmerica Partners
CAPL
$862M
$911 ﹤0.01%
40
+1
+3% +$22
LSTA icon
363
Lisata Therapeutics
LSTA
$9.82M
$909 ﹤0.01%
333
-333
-50% -$782
IBB icon
364
iShares Biotechnology ETF
IBB
$9.82B
$825 ﹤0.01%
6
VGAS icon
365
Verde Clean Fuels
VGAS
$27.3M
$590 ﹤0.01%
250
PSCC icon
366
Invesco S&P SmallCap Consumer Staples ETF
PSCC
$40.9M
$582 ﹤0.01%
15
ITOT icon
367
iShares Core S&P Total US Stock Market ETF
ITOT
$97.8B
$551 ﹤0.01%
5
RWL icon
368
Invesco S&P 500 Revenue ETF
RWL
$9.95B
$441 ﹤0.01%
5
IYE icon
369
iShares US Energy ETF
IYE
$1.78B
$404 ﹤0.01%
9
NKTR icon
370
Nektar Therapeutics
NKTR
$2.53B
$396 ﹤0.01%
47
-53
-53% -$401
FNCL icon
371
Fidelity MSCI Financials Index ETF
FNCL
$2.41B
$352 ﹤0.01%
7
GME icon
372
GameStop
GME
$8.43B
$351 ﹤0.01%
20
FHLC icon
373
Fidelity MSCI Health Care Index ETF
FHLC
$3.42B
$343 ﹤0.01%
5
GLP icon
374
Global Partners
GLP
$1.69B
$321 ﹤0.01%
8
+1
+14% +$34
WMB icon
375
Williams Companies
WMB
$87.9B
$303 ﹤0.01%
9

Similar funds

Founders Capital Management (Texas)'s Q4 2023 Portfolio in Review

As of Q4 2023, Founders Capital Management (Texas) held 410 positions worth $138M, up 5.1% from $131M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Founders Capital Management (Texas)'s Q4 2023 filing shows 8 new, 43 increased, 63 reduced and 29 closed positions. Its largest new stake was Ulta Beauty: 50 shares worth $24.5K. The largest sale was Pfizer, an estimated $781K.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Industrials and Energy.

  • Founders Capital Management (Texas)'s largest Q4 2023 buy was Ulta Beauty: 50 shares worth $24.5K.
  • Founders Capital Management (Texas) added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q4 2023, an estimated $76.2K increase.
  • Founders Capital Management (Texas)'s biggest Q4 2023 reduction was Pfizer, cutting an estimated $781K.
  • Founders Capital Management (Texas) fully exited Olympic Steel in Q4 2023, selling an estimated $50.6K.
  • Founders Capital Management (Texas)'s ten largest holdings make up 50% of its $138M portfolio in Q4 2023.
  • Founders Capital Management (Texas) opened 8 new positions and closed 29 in Q4 2023.
  • Founders Capital Management (Texas)'s portfolio value rose 5.1% quarter-over-quarter to $138M.

Based on Founders Capital Management (Texas)'s 13F filing for Q4 2023, filed 8 Jan 2024.